Bio-Works Technologies AB (FRA:1BD) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1BD Bio-Works Technologies AB FRA:1BD
49 GF Score
Price €0.29
GF Value €0.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bio-Works Technologies AB Net Loan?

Net Loan only applies to banks and insurance companies.

FRA:1BD
49GF Score
Bio-Works Technologies AB FRA:1BD
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bio-Works Technologies AB (FRA:1BD) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Works Technologies AB stock appears to be undervalued. The current stock price of €0.29 is trading 10.6% below its estimated GF Value™ of €0.32. GuruFocus considers Bio-Works Technologies AB to be Modestly Undervalued.

Key valuation signals for FRA:1BD:

  • Net Loan:
  • GF Value™: €0.32 vs. price of €0.29 (10.6% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the FRA:1BD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Works Technologies AB Business Description

Other Exchanges BIOWKS:Sweden
Address Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
49GF Score

Get the complete analysis for FRA:1BD

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.32
GF Value